![]() |
|
|
Foods and Nutrition Consultant, Lothian, MD 20711
2To whom correspondence should be addressed. E-mail: gbeecher{at}earthlink.net.
Flavonoids and their polymers constitute a large class of food constituents, many of which alter metabolic processes and have a positive impact on health. Flavonoids are a subclass of polyphenols. They generally consist of two aromatic rings, each containing at least one hydroxyl, which are connected through a three-carbon "bridge" and become part of a six-member heterocyclic ring. The flavonoids are further divided into subclasses based on the connection of an aromatic ring to the heterocyclic ring, as well as the oxidation state and functional groups of the heterocyclic ring. Within each subclass, individual compounds are characterized by specific hydroxylation and conjugation patterns. Many flavonoids in foods also occur as large molecules (tannins). These include condensed tannins (proanthocyanidins), derived tannins and hydrolysable tannins. For proanthocyanidins, three subclasses (15 characterized) have been identified in foods. Monomers are connected through specific carbon-carbon and ether linkages to form polymers. Derived tannins are formed during food handling and processing, and found primarily in black and oolong teas. Flavonoids are widely distributed in nature, albeit not uniformly. As a result, specific groups of foods are often rich sources of one or more subclasses of these polyphenols. The polyphenolic structure of flavonoids and tannins renders them quite sensitive to oxidative enzymes and cooking conditions. Scientists in several countries have estimated intakes of a few subclasses of flavonoids from limited food composition databases. These observations suggest large differences in consumption, due in part to cultural and food preferences among populations of each country.
KEY WORDS: flavonoids tannins thearubigins polyphenols detary intake
This article has been cited by other articles:
![]() |
R. Corder Red wine, chocolate and vascular health: developing the evidence base Heart, July 1, 2008; 94(7): 821 - 823. [Full Text] [PDF] |
||||
![]() |
U. Nothlings, S. P. Murphy, L. R. Wilkens, B. E. Henderson, and L. N. Kolonel Flavonols and Pancreatic Cancer Risk: The Multiethnic Cohort Study Am. J. Epidemiol., October 15, 2007; 166(8): 924 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ung and S. Nagar Variable Sulfation of Dietary Polyphenols by Recombinant Human Sulfotransferase (SULT) 1A1 Genetic Variants and SULT1E1 Drug Metab. Dispos., May 1, 2007; 35(5): 740 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. K. Chun, S. J. Chung, and W. O. Song Estimated Dietary Flavonoid Intake and Major Food Sources of U.S. Adults J. Nutr., May 1, 2007; 137(5): 1244 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Erdman Jr., D. Balentine, L. Arab, G. Beecher, J. T. Dwyer, J. Folts, J. Harnly, P. Hollman, C. L. Keen, G. Mazza, et al. Flavonoids and Heart Health: Proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC J. Nutr., March 1, 2007; 137(3): 718S - 737S. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kwon, P. Eck, S. Chen, C. P. Corpe, J.-H. Lee, M. Kruhlak, and M. Levine Inhibition of the intestinal glucose transporter GLUT2 by flavonoids FASEB J, February 1, 2007; 21(2): 366 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stangl, H. Dreger, K. Stangl, and M. Lorenz Molecular targets of tea polyphenols in the cardiovascular system Cardiovasc Res, January 15, 2007; 73(2): 348 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Peluso Flavonoids Attenuate Cardiovascular Disease, Inhibit Phosphodiesterase, and Modulate Lipid Homeostasis in Adipose Tissue and Liver Experimental Biology and Medicine, September 1, 2006; 231(8): 1287 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagar, S. Walther, and R. L. Blanchard Sulfotransferase (SULT) 1A1 Polymorphic Variants *1, *2, and *3 Are Associated with Altered Enzymatic Activity, Cellular Phenotype, and Protein Degradation Mol. Pharmacol., June 1, 2006; 69(6): 2084 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gao, A. Xu, C. Krul, K. Venema, Y. Liu, Y. Niu, J. Lu, L. Bensoussan, N. P. Seeram, D. Heber, et al. Of the Major Phenolic Acids Formed during Human Microbial Fermentation of Tea, Citrus, and Soy Flavonoid Supplements, Only 3,4-Dihydroxyphenylacetic Acid Has Antiproliferative Activity J. Nutr., January 1, 2006; 136(1): 52 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ralston, S. Subramanian, M. Matsuno, and O. Yu Partial Reconstruction of Flavonoid and Isoflavonoid Biosynthesis in Yeast Using Soybean Type I and Type II Chalcone Isomerases Plant Physiology, April 1, 2005; 137(4): 1375 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Brusselmans, R. Vrolix, G. Verhoeven, and J. V. Swinnen Induction of Cancer Cell Apoptosis by Flavonoids Is Associated with Their Ability to Inhibit Fatty Acid Synthase Activity J. Biol. Chem., February 18, 2005; 280(7): 5636 - 5645. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Mennen, D. Sapinho, A. de Bree, N. Arnault, S. Bertrais, P. Galan, and S. Hercberg Consumption of Foods Rich in Flavonoids Is Related to a Decreased Cardiovascular Risk in Apparently Healthy French Women J. Nutr., April 1, 2004; 134(4): 923 - 926. [Abstract] [Full Text] [PDF] |
||||